Lower urinary tract symptoms evaluation with uroflowmetry in patients with benign prostatic hyperplasia
DOI:
https://doi.org/10.18203/2320-6012.ijrms20240839Keywords:
Benign prostatic hyperplasia, Lower urinary tract symptoms, UroflowmetryAbstract
Background: Uroflowmetry, a non-invasive urodynamic technique, is commonly employed in evaluating patients with potential lower urinary tract dysfunction. Accurate assessment of the severity of lower urinary tract symptoms (LUTS) can be achieved through the utilization of various validated questionnaires, such as the International Prostate Symptom Score (IPSS). The objective of this study was to investigate the correlation between uroflowmetry parameters and the severity of symptoms.
Methods: Fifty patients with LUTS caused by benign prostatic hyperplasia were evaluated by using uroflowmetry, IPSS, prostate volume estimation from May 2022 to December 2023. The correlations between these parameters were quantified by means of Spearman correlation co-efficients.
Results: Significant statistical correlations were identified between the IPSS and uroflowmetry outcomes, including peak flow rate, average flow rate, and post-void residual urine. However, no correlation was observed between the IPSS and measurements of prostate volume.
Conclusions: A positive correlation was observed between the measured peak flow rate through uroflowmetry and the severity of lower urinary tract symptoms.
References
Malik MA, Khan JH, Gondal WS, Bajwa IA. Role of uroflowmetry in lower urinary tract symptoms evaluation due to benign prostatic hyperplasia (BPH). Special Edition Annals. 2010;16(1):34-8.
Guler C, Tuzel E, Dogantekin E, Kiziltepe G. Does sildenafil affect uroflowmetry values in men with lower urinary tract symptoms suggestive of benign prostatic enlargement? Urol Int. 2008;80(2):181-5.
Agrawal CS, Chalise PR, Bhandari BB. Correlation of prostate volume with international prostate symptom score and quality of life in men with benign prostatic hyperplasia. Nepal Med Coll J. 2008;10(2):104-7.
Von GB. Analysis of micturition; a new method of recording the voiding of the bladder. ActaChir Scand. 1957;112(3-4):326-40.
De La Rosette JJ, Witjes WP, Debruyne FM, Kersten PL, Wijkstra H. Improved reliability of uroflowmetry investigations: results of a portable home-based uroflowmetry study. Br J Urol. 1996;78(3):385-90.
Neveus T, von Gontard A, Hoebeke P, Hjalmas K, Bauer S, Bower W, et al. The standardization of terminology of lower urinary tract function in children and adolescents: report from the Standardisation Committee of the International Children’s Continence Society. J Urol. 2006;176(1):314-24.
Djavan B, Margreiter M, Dianat SS. An algorithm for medical management in male lower urinary tract symptoms. Curr Opin Urol. 2011;21(1):5-12.
Jensen KM. Uroflowmetry in elderly men. World J Urol. 1995;13(1):21-3.
Mebust WK, Holtgrewe HL, Cockett ATK, Peters PC. and Writing Committee. Transurethral prostatectomy: immediate and postoperative complications. a cooperative study of 13 participating institutions evaluating 3885 patients. J. Urol. 1989;141:243-47.
Vesely S, Knutson T, Damber JE, Dicuio M, Dahlstrand C, et al. Relationship between age, prostate volume, prostate-specific antigen, symptom score and uroflowmetry in men with lower urinary tract symptoms. J Urol Nephrol. 2003;37(4):322-8.
Dicuio M, Pomara G, Vesely S, Morelli G, Fabris FM, Ales V, et al. The use of prostatic intravesical protrusion correlated with uroflowmetry: a new method to measure obstruction in patients with LUTS due to BOO without using P/F studies. Arch Ital Urol Androl. 2005;77(1):50-3.
Ezz el Din K, Kiemeney LA, de Wildt MJ, Debruyne FM, de la Rosette JJ. Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score. Urolo. 1996;48(3):393-7.
Kolman C, Girman CJ, Jacobsen SJ, Lieber MM. Distribution of post-void residual urine volume in randomly selected men. J Urol. 1999;161(1):122-7.
Barry MJ, Girman CJ, O'Leary MP, Walker-Corkery ES, Binkowitz BS, Cockett AT, et al. Using repeated measures of symptom score, uroflowmetry and prostate specific antigen in the clinical management of prostate disease. Benign Prostatic Hyperplasia Treatment Outcomes Study Group. J Urol. 1995;153(1):99-103.
Bosch JLHR, Hop WCJ, Kirkels WJ, Schrosber FH. The International Prostate Symptom Score in a community based sample of men between 55 and 74 years of age; prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume. Br J Urol. 1995;75(5):622-30.
Din KEE, Kiemeney LAAM, Wildt MJAM, Debruyne FMJ, Rosette JJMC. Correlation between uroflowmetry, prostate volume, postvoid residual, and lower urinary tract symptoms measured by the International Prostate Symptom Score. Urology. 1996;48(3):393-7.
Wadie BS, Ibrahim E-HI, de la Rosette JJ, Gomha MA, Ghoneim MA. The relationship of the International Prostate Symptom Score and objective parameters for diagnosing bladder outlet obstruction. Part 1: when statistics fail. J Urol. 2001;165(1):32-4.
